SCHEMBL302958

SCHEMBL302958

CCC(=O)N[C@@H](CCSC)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
MAPK1 P28482 2/20 0.52
ALDH1A1 P00352 2/20 0.52
USP2 O75604 2/20 0.52
TP53 P04637 1/20 0.52
ALOX15 P16050 1/20 0.52
FNTA P49354 5/20 0.50
FNTB P49356 5/20 0.50
PGGT1B P53609 1/20 0.49
NPSR1 Q6W5P4 2/20 0.49
FOLH1 Q04609 1/20 0.47
TSHR P16473 1/20 0.47
CA2 P00918 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL987347 1.00 LMNA (0.53) LMNAMAPK1ALDH1A1USP2TP53
SCHEMBL302957 1.00 LMNA (0.53) LMNAMAPK1ALDH1A1USP2TP53
Hydrochloric Acid SCHEMBL10423086 0.86 LTA4H (0.45) LMNAMAPK1ALDH1A1USP2TP53
SCHEMBL302152 0.86 FNTA (0.58) LMNAMAPK1ALDH1A1USP2TP53
SCHEMBL302151 0.86 FNTA (0.58) LMNAMAPK1ALDH1A1USP2TP53
SCHEMBL4952873 0.85 LMNA (0.53) LMNAMAPK1ALDH1A1USP2TP53
SCHEMBL25724229 0.85 LMNA (0.53) LMNAMAPK1ALDH1A1USP2TP53
SCHEMBL6308975 0.85 MAPK1 (0.54) LMNAMAPK1ALDH1A1USP2TP53
SCHEMBL7636762 0.84 FNTA (0.56) LMNAMAPK1ALDH1A1USP2TP53
SCHEMBL7636751 0.84 FNTA (0.56) LMNAMAPK1ALDH1A1USP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO claimed
EP-2326724-B1 PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE EVONIK DEGUSSA GMBH (DE) 2019-05-22 EP claimed
US-20180070612-A1 RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME WAN FENG (US) 2018-03-15 US claimed
US-8748136-B2 Producing methionine without N-acyl-methionine METABOLIC EXPLORER (FR) 2014-06-10 US claimed
JP-2012500623-A 2012-01-12 JP claimed
EP-2331684-A1 PRODUCTION OF N-ACYLATED SULPHUR-CONTAINING AMINO ACIDS WITH MICROORGANISMS HAVING ENHANCED N-ACYLTRANSFERASE ENZYMATIC ACTIVITY Metabolic Explorer (FR) 2011-06-15 EP claimed
WO-2010020682-A1 PRODUCTION OF N-ACYLATED SULPHUR-CONTAINING AMINO ACIDS WITH MICROORGANISMS HAVING ENHANCED N-ACYLTRANSFERASE ENZYMATIC ACTIVITY METABOLIC EXPLORER (FR) 2010-02-25 WO claimed
US-20100047879-A1 PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE EVONIK OPERATIONS GMBH (DE) 2010-02-25 US claimed
US-20100047880-A1 PRODUCTION OF N-ACYLATED SULPHUR-CONTAINING AMINO ACIDS WITH MICROORGANISMS HAVING ENHANCED N-ACYLTRANSFERASE ENZYMATIC ACTIVITY METABOLIC EXPLORER (FR) 2010-02-25 US claimed
US-20090186853-A1 COMPOSITIONS COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF YU RUEY J 2009-07-23 US claimed
EP-1865953-A4 COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF YU RUEY J (US) 2008-04-30 EP claimed
EP-1865953-A2 COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF Yu, Ruey J., Dr. (US) 2007-12-19 EP claimed
WO-2006101940-A2 COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF YU, RUEY, J. (US) 2006-09-28 WO claimed
US-20060211754-A1 Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof YU RUEY J 2006-09-21 US claimed
US-20050171194-A1 Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions YU RUEY J (US) 2005-08-04 US claimed
WO-2005055947-A2 ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS YU RUEY J (US) 2005-06-23 WO claimed
EP-0906099-A4 A METHOD OF TREATING CANCER MERCK & CO INC (US) 2001-02-07 EP claimed
EP-0906099-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 1999-04-07 EP claimed
WO-1997036587-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1997-10-09 WO claimed
US-20250295713-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2025-09-25 US disclosed
US-20250258146-A1 QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP HUMAN METABOLOMICS INSTITUTE INC. (CN) 2025-08-14 US disclosed
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO disclosed
US-12064459-B2 Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes DERMBIONT, INC. (US) 2024-08-20 US disclosed
CN-116178624-B Isocyanate stabilizer, isocyanate composition and polyurethane resin 万华化学集团股份有限公司 2024-06-25 CN disclosed
EP-4386090-A1 METHOD FOR DETERMINING AND IMPROVING THE POTENTIAL EFFICACY OF ANTICANCER TREATMENT ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (FR) 2024-06-19 EP disclosed
CN-116178624-A Isocyanate stabilizer, isocyanate composition and polyurethane resin 万华化学集团股份有限公司 2023-05-30 CN disclosed
US-20230158088-A1 COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, ENHANCING DRUG POTENCY AND TREATING VIRAL INFECTIONS, AND METHODS FOR MAKING AND USING SAME PERSEPHONE BIOSCIENCES INC (US) 2023-05-25 US disclosed
US-20220160617-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2022-05-26 US disclosed
US-20210386802-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2021-12-16 US disclosed
US-20210361725-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2021-11-25 US disclosed
US-11040077-B2 Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes DERMBIONT, INC. (US) 2021-06-22 US disclosed
US-20210038654-A1 COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, ENHANCING DRUG POTENCY AND TREATING CANCER, AND METHODS FOR MAKING AND USING SAME PERSEPHONE BIOSCIENCES INC. 2021-02-11 US disclosed
US-20200345799-A1 COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES DERMBIONT, INC. 2020-11-05 US disclosed
EP-2326724-B1 PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE EVONIK DEGUSSA GMBH (DE) 2019-05-22 EP disclosed
US-20180070612-A1 RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME WAN FENG (US) 2018-03-15 US disclosed
EP-3273795-A1 RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME Benemilk Oy (FI) 2018-01-31 EP disclosed
WO-2016154574-A1 RUMEN BY-PASS ANIMAL FEED COMPOSITION AND METHOD OF MAKING SAME BENEMILK OY (FI) 2016-09-29 WO disclosed
US-8748136-B2 Producing methionine without N-acyl-methionine METABOLIC EXPLORER (FR) 2014-06-10 US disclosed
US-8143031-B2 Production of N-acylated sulphur-containing amino acids with microorganisms having enhanced N-acyltransferase enzymatic activity METABOLIC EXPLORER (FR) 2012-03-27 US disclosed
EP-2331684-A1 PRODUCTION OF N-ACYLATED SULPHUR-CONTAINING AMINO ACIDS WITH MICROORGANISMS HAVING ENHANCED N-ACYLTRANSFERASE ENZYMATIC ACTIVITY Metabolic Explorer (FR) 2011-06-15 EP disclosed
EP-2326724-A1 PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE Metabolic Explorer (FR) 2011-06-01 EP disclosed
US-20110020914-A1 METHODS FOR ENHANCING GROWTH OF ORGANISMS IN AN AQUEOUS GROWTH MEDIUM NOVUS INTERNATIONAL INC (US) 2011-01-27 US disclosed
WO-2010020682-A1 PRODUCTION OF N-ACYLATED SULPHUR-CONTAINING AMINO ACIDS WITH MICROORGANISMS HAVING ENHANCED N-ACYLTRANSFERASE ENZYMATIC ACTIVITY METABOLIC EXPLORER (FR) 2010-02-25 WO disclosed
WO-2010020681-A1 PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE METABOLIC EXPLORER (FR) 2010-02-25 WO disclosed
US-20100047879-A1 PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE EVONIK OPERATIONS GMBH (DE) 2010-02-25 US disclosed
US-20100047880-A1 PRODUCTION OF N-ACYLATED SULPHUR-CONTAINING AMINO ACIDS WITH MICROORGANISMS HAVING ENHANCED N-ACYLTRANSFERASE ENZYMATIC ACTIVITY METABOLIC EXPLORER (FR) 2010-02-25 US disclosed
US-20090186853-A1 COMPOSITIONS COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF YU RUEY J 2009-07-23 US disclosed
EP-1865953-A4 COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF YU RUEY J (US) 2008-04-30 EP disclosed
EP-1865953-A2 COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF Yu, Ruey J., Dr. (US) 2007-12-19 EP disclosed
US-20070231377-A1 COMPOSITIONS FOR PROMOTING HAIR GROWTH NOVUS INTERNATIONAL INC. (US) 2007-10-04 US disclosed
WO-2006101940-A2 COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF YU, RUEY, J. (US) 2006-09-28 WO disclosed
US-20060211754-A1 Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof YU RUEY J 2006-09-21 US disclosed
US-20050171194-A1 Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions YU RUEY J (US) 2005-08-04 US disclosed
WO-2005055947-A2 ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS YU RUEY J (US) 2005-06-23 WO disclosed
US-6645519-B2 Preparing a precursor for taurine biosynthesis in form of protected amino acids resistant to degradation in a rumen; feeding feedstuffs containing protected amino acids to farm animals, so as to breed the farm animals; milking farm animals GYEONG-BUK DAEGU DAIRY CO-OPERATIVES (KR) 2003-11-11 US disclosed
US-20020110589-A1 Method for producing taurine-enriched milk GYEONG-BUK DAIRY CO-OPERATIVES (KR) 2002-08-15 US disclosed
EP-0783518-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO. INC. (US) 1997-07-16 EP disclosed
US-3963573-A Process for producing N-acyl-L-methionine THE PROCTER & GAMBLE COMPANY (US) 1976-06-15 US disclosed
US-3963573-A Process for producing N-acyl-L-methionine THE PROCTER & GAMBLE COMPANY (US) 1976-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070231377-A1 COMPOSITIONS FOR PROMOTING HAIR GROWTH FGF1, MTR, HGF LMNA 4267/4885MAPK1 3232/4885ALDH1A1 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.